This study was done on 143 patients (75 in-patients and 68 out-patients) in Zagazig University Hospitals who were suspected to have urinary tract infections (UTIs). Their ages ranged from 12 to 61years. One hundred and twenty four of urine samples that collected from patients yielded positive culture on MacConkey's agar. The identification of isolates was done by biochemical tests and confirmed by automated Vitek 2 system. The results showed that E. coli was the most causative organisms of UTIs 44 isolates (35.4%). Antimicrobial susceptibility test by modified Kirby-Bauer disc diffusion method was performed to select multi drugs resistant (ESβL) production according to the Clinical and Laboratory Standards Institute (CLSI) recommendation. The PCR technique was applied to detect the ESβL genes that responsible for the resistance, it was found that the TEM gene was the predominate gene (100%) amongst ESβL E. coli followed by SHV (90%) but CTX-M gene was absent. The coexistence of more than one type of β-lactamase enzymes was detected and represented (30%) of ESβL E. coli. From these results we can concluded that the Prevalence of ESβL producing E. coli was (22.7%) among E. coli isolates. TEM and SHV genes were the most frequent genes and the coexistence of ESβL, AmpC, OXA-1 was detected in (30%) of isolates.
Introduction
Urinary tract infections (UTIs) are the most common human bacterial infections. Each year about 150 million people developed UTIs [1] . UTI
Detection of Extended Spectrum β-lactamases Phenotypic studies A) Screening for ESβL production using Disc Diffusion method
This screening method is based on measuring the specific zone diameters for the antibiotic discs cefpodoxime (CPD, 10 μg), ceftazidime (CAZ, 30 μg), aztreonam (ATM, 30 μg), ceftriaxone (CRO, 30 μg) and cefotaxime (CTX, 30 μg). CLSI recommends a zone diameter of ≤ 17 mm for cefpodoxime, ≤ 22 mm for ceftazidime, ≤ 27 mm for aztreonam, ≤ 25 mm for ceftriaxone and ≤ 27 mm for cefotaxime. [14] . When the most of these diameters were obtained, this indicated suspected ESβL production; there after a phenotypic confirmation test was done to ensure the diagnosis [14] . B) Phenotypic confirmatory tests for ESβL production 1-Combined disc method Cephalosporin / clavulante combination discs were used to confirm the suspected ESβL strains by the combination discs diffusion method. [15] . Briefly, the overnight growth in broth of Gram negative bacteria was adjusted to 0.5 McFarland Standard. By using a sterilized cotton swab the bacterial suspension was spread on Muller Hinton agar (Oxoid, UK). After incubation at room temperature for 15 min, four discs were placed on the plates: Ceftazidime (30 μg), ceftazidime / clavulanic acid (30/10 μg), cefotaxime (30 μg), cefotaxime / clavulanic acid (30/10 μg). An increase in zone size > 5 mm than zone size once tested alone was accepted as confirmation of ESβL production.
2-ESβL -E-test
The ESβL -E-Test strips were obtained from (Liofilchem) including ceftazidime / ceftazidime + clavulanic acid (CAZ/CAL) and cefotaxime and cefotaxime + clavulanic acid (CTX/CTL) in accordance with the manufacturer's instructions. One end of each strip contains a gradient concentration of either ceftazidime (CAZ) (MIC range 0.5 to 32 μg/ml) or cefotaxime (CTX) (MIC range of 0.25 µg to 16 µg). The other end of the strip with a gradient of ceftazidime plus a constant concentration of clavulanate CAZ/CAL (0.064-4 μg/ml plus 4 μg/ml of clavulanic acid) or with a gradient of cefotaxime plus a constant concentration of clavulanate CTX/CTL (0.25 µg-16 µg plus 4 µg of clavulanic acid) [16, 17] .After overnight growth, the organism was emulsified in saline solution to a turbidity of 0.5 McFarland standard. The suspension was spread on a Muller Hinton agar plate with a cotton swab. The plates were left for 5-15 min to dry, then the E-Test strips were placed on them and incubated at 35˚C for 18 h. According to the manufacturer, if the ceftazidime (CAZ) MIC/ceftazidime clavulanic acid (CAL) MIC ratio and the ratio for cefotaxime (CTX) MIC/cefotaxime clavulanic acid (CTL) MIC ≥ 8 indicates the presence of ESβL. Also, the presence of an ESβL is confirmed either by the appearance of a phantom zone or deformation of the cefotaxime or ceftazidime ellipse or when the MIC of cefotaxime or ceftazidime is reduced by ≥3log 2 dilutions in the presence of clavulanic acid. Molecular studies Molecular studies were done in the Animal Health Research Institute in GIZA for determination of the genetic type of β-lactamase by polymerase chain reaction (PCR). All phenotypically confirmed ESBL producing strains were investigated to determine the probable type of β-lactamase enzyme which was responsible for resistance. According to QIAprep Spin Miniprep kits hand book, the extraction of plasmid DNA was done as follows, the pelleted bacterial cells were resuspended in 250 μl Buffer P1 then they were transfered to a microcentrifuge tube. 250 μl Buffer P2 was added and the tube was gently inverted 4-6 times to mix. After this 350 μl buffer N3 was added and the tube was inverted immediately but gently 4-6 times then centrifuged for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge, the supernatants were applied to the QIAprep spin column by decanting or pipetting, then centrifuged for 30-60 sec. The flow-through was discarded and the QIAprep spin column was washed by adding 0.5 ml buffer PB and centrifuged for 30-60 sec.the last step was repeated but by using of 0.75 ml Buffer PE, centrifuged for 30-60 sec, the flow-through was discarded, and centrifuged for an additional 1 min. to remove residual wash buffer. Finally, the QIAprep column was placed in a clean 1.5 ml microcentrifuge tube. To elute DNA, 50 μl Buffer EB(10 m MTris·Cl, pH 8.5) was added or water to the center of each QIAprep spin column, let stand for 1 min., and centrifuge for 1 min after extraction step preparation of PCR master mix occured according to Emerald Amp GT PCR mastermix (Takara) Code No. RR310A, The cycling conditions of the primers during cPCR [18, 19, 20, 21] . according to specific authors and Emerald Amp GT PCR mastermix (Takara) kit. [22] .
Then the ladder was mixed gently by pipetting up and down. 6 μl of the required ladder were directly loaded. Finally, Agarose gel electrophoreses were prepared [22] .
Results
Out of one hundred and forty three urine samples collected from patients suspected to have UTIs at Zagazig University Hospitals, One hundred and twenty four of urine samples showed positive growth on MacConkey agar, included 60 samples from in-patients and 64 from out-patients, the patients involved 76 females and 48 males. After the detection of cultured organisms, E. coli was represented (35.4%), Klebsiella was represented (30.6%) and other non-lactose fermented organisms were represented (33.8%). Among 44 E. coli isolates 20 isolates (33.33%) were obtained from UTI in-patients and 24 isolates (37.5%) from UTI out-patients. The distribution of urinary isolates among in-patients and out-patients in Zagazig Hospitals are shown in the Table (1) .
Antimicrobial susceptibility test
Antibiotics sensitivity of E. coli isolates showed that the isolates were mostly sensitive to Meropenem and Imipenem (97.7%), while they were sensitive to Cefotaxime (63.7%), Ceftazidime, Gentamicin, Trimethoprim/ Sulfamethoxazole (56.8%), Nitrofurantoin (50%), Ceftriaxone (43.1%), Amoxicillin/ Clavulanate (36.3%) and Ciprofloxacin (20.4%).
Screening of ESBL production
Preliminary screening tests showed that 27.2% (12/44) of E. coli isolates were potential ESβL producers. Confirmatory tests (Combined Disc method and ESβL-E-Test) were carried out to confirm the production of ESβL (Figuers1, 2). Results confirmed that 83.3% (10/12) of E. coli isolates were ESBL producers. Determination of the genotype of β-lactamase by PCR All confirmatory screened isolates were analyzed by PCR to determine the probable type of ESβL gene which is responsible for resistance. It was found that TEM gene was the mostly distributed genes among E. coli isolates (100%) as shown in Figure ( Three isolates exhibited resistance to combination of cephalosporine with clavulanic acid and by PCR analysis it was found that all of three isolates contained DHA and OXA-1, two of them contained CIT where no one contained FOX as shown in Figure (3d) . Only one isolate was resistant to carbapenem group included (impenem and meropenem) and the PCR analysis demonstrated that this isolate contained KPC and NDM and VIM as shown in Figure (3e) . The present results showed that all strains produced more than one type of β-lactamase expect isolate no (59) that produced only TEM enzyme while there were nine strains produced both enzymes TEM and SHV (90%), two of them produced TEM, SHV, OXA-1, DHA and CIT enzymes (20%), only one strain produced TEM, SHV, OXA-1, DHA, NDM, VIM, KPC enzymes (10%) as shown in Table ( 2). , who found that non-lactose fermenters were the least dominant uropathogens causing UTIs. Through the biochemical and morphological tests that administrated to detect the causative uropathogens we found that E. coli was the dominant organism 44(35.8%) among the isolates. These results were in agreement with these obtained from alternative studies conducted worldwide which approved that E. coli is the major pathogen that cause UTIs [28, 29] . And in accordance with many previous studies conducted in Bangladesh those also considered E. coli to be the most prevalent pathogen associated with UTI [30, 31] . This could as a result of E. coli is amajor normal flora in the gut however within the presence of poor hygiene will lead to cross contamination and then urinary tract infection. UTIs are usually caused by UPEC strains which accounts for around 90% of all UTIs [32] . E coli causes several infections and is frequently associated with urinary tract infections in both nosocomial and community settings [27, 33] . In the present study the leading pathogens of UTIs among out-patients were E. coli 36.9% and K. pneumoniae 26.1%. These results were nearly matching with the results of North American Urinary Tract Infection Collaborative Alliance (NAUTICA) [3] , which approved that the common pathogen causing community settings was E. coli 57.5% followed by K. pneumoniae 23.5%. on the other hand, we found that the leading pathogen causing UTIs among inpatients was K. pneumoniae (35.6%) which, outnumbered E. coli (33.8%) for overall prevalence of nosocomial UTI. These results were compatible with what was observed by Taher and Ali [34] in Iran who found that the rate for K. pneumoniae 46% and E. coli 25%, and also similar to Mirsalehian et al. [35] . Who reported that the rate of nosocomial UTI caused by K. pneumoniae was 36.66% which was higher than those caused by E. coli 20%. Antimicrobial therapy remains the standard treatment for UTIs, and therefore the most active of those agents being third-generation cephalosporins and carbapenem drugs [36] . However, the worldwide emergence of ESβL, AmpC β-lactamases and carbapenemase producing E. coli poses a great challenge for the clinical therapy of infections caused by these organisms leading to increased morbidity and mortality [36, 37] . The prompt detection of those multi-resistant organisms eventually enhances patient diagnosis and limits potential abuse of antimicrobial agents [36] .
In the present study the preliminary screening of ESBL production led to 12 isolates that were suspected as ESBL producer and by using of confirmation methods including combined disc diffusion and E-tests methods and we found that about 10 isolates (83%) were ESβL producer.
The results also showed that there were 7 isolates that inhibited by the combination of cephalosporine with clavulanic acid but the isolates that resistant to this combination were suspected as ESβL and AmpC co-producer. As, Clavulanic acid may induce expression of high-level AmpC production and may then antagonize rather than protect the antibacterial activity of the partner β-lactam [38] . Thus, the presence of an ESBL can be masked by the expression of an AmpC-type enzyme in the same strain (by masking any synergy with ESβL) [39] . During this work the results that were obtained by using the Combined Disc method were similar to that revealed by using E-tests method expect in isolates no 102, 121. As, those isolates responded to the inhibition with combined disc of cefotaxime with clavulanic acid and provide no reaction with E-tests strips which contained MIC cefotaxime with clavulanic it might occur due to the concentration gradient is not as extensive as that recommended by CLSI, they yield more inconclusive results than CLSI phenotypic confirmatory test. These findings showed that TEM (100%) gene predominated, the SHV (90%) and CTX-M not detected. These genes responsible for ESβL production. These results are in accordance with the results of a study that obtained by Yazdi et al. [40] . who found that TEM was 87.1% and SHV was 70.6%. On other hands, our results were disagreed with those results of Eftekhar et al [41] study, which suggested that SHV percentage (43.1%) exceeded that of TEM (35.2%), and also in contrast with the results declared by Shahid et al [42] , in which CTX-M (28.8%) exceeded SHV (13.7%), and the results obtained by Ahmed et al [43] , which found that CTX-M exceeded TEM., and also contrasted with previous research from North Palestine, which accounted that the occurance of CTX-M-type and TEM-type ESβL was 100% and 32%, respectively, among ESβL -producing E. coli detected by PCR [44] . Several alternative studies performed throughout the world demonstrated variable results. The differences between our study results and those of other authors indicated that the prevalence and type of ESβL genes may vary from one geographical region to another. or may be due to different races in different studies. [45] .
In this study detection of OXA-1 and AmpC β-lactamases genes among the isolates showed that the DHA, OXA-1 are the predominant genes followed by CIT subtype of AmpC genes Whereas, several other studies from various parts of the world announced the presence of different subtypes among isolates of E. coli [46, 47] . In this work the co-production of both AmpC and ESβL in the isolates was observed. It was represented by 30% of all isolates which in contrasted with the study by Mathur et al [48] who found that the co-production was 1.25%. The coexistence of different classes of β-lactamases in a single bacterial pathogen may pose treatment challenges, and this will seriously restricted treatment options. In addition, may pose diagnostic challenge, such as highlevel expression of AmpC β-lactamases may prevent the recognition of the ESβL, it may lead to the using of an unsuitable antimicrobial therapy and the result may be fatal [49] . The expression of both AmpC β-lactamases and ESβL enzymes in a single isolate decreases the efficacyof the β-lactam/β-lactamase inhibitor combinations [50] . It was observed through this work that ESBL isolates were significantly associated with carbapenemase producers. Notably, one of E. coli isolates (10%) co-expressed ESβL and carbapenemases. The co-existence of different ESβL enzymes in E. coli isolates has similarly been declared elsewhere, such as in Taiwan (40.6%). Infections with such highly resistant organisms may lead in repeated hospitalization or increase the mortality. Hence, it is basic to apply better screening conventions to detect these isolates and to devise an exact treatment policy for patient at high risk of infection by such isolates [51] . Results also, revealed that the rate of ESβL producing E coli was 22.7% that consistent with the findings of other studies which showed low rates of ESβL
